Preview

Бюллетень сибирской медицины

Расширенный поиск

Вульводиния – мультидисциплинарная проблема

https://doi.org/10.20538/1682-0363-2020-1-114-124

Полный текст:

Аннотация

Обзор литературы посвящен проблеме вульводинии как мультидисциплинарной проблеме. В статье обобщены сведения об этиологии и патогенетических факторах развития заболевания, затронуты аспекты диагностики и лечения данной формы хронической генитальной боли. Несмотря на распространенность патологии, женщины с болью в области вульвы нередко остаются не диагностированными и не получают адекватную терапевтическую и психоэмоциональную поддержку. В настоящее время актуальность представляет поиск определения, классификации, распространенности, патофизиологических факторов возникновения и адекватной персонализированной терапии данной нозологии.

Об авторах

К. Р. Бахтияров
Первый Московский государственный медицинский университет им. И.М. Сеченова (Первый МГМУ им. И.М. Сеченова); Сеть семейных медицинских центров (ССМЦ)
Россия

д-р мед. наук, профессор, кафедра акушерства, гинекологии и перинатологии; руководитель акушерско-гинекологической службы 

Россия, 119991, г. Москва, ул. Трубецкая, 8, стр. 2

Россия, 107120, г. Москва, ул. Сергия Радонежского, 5/2, стр. 1



П. В. Буданов
Первый Московский государственный медицинский университет им. И.М. Сеченова (Первый МГМУ им. И.М. Сеченова); Сеть семейных медицинских центров (ССМЦ)
Россия

д-р мед. наук, профессор, кафедра акушерства, гинекологии и перинатологии; врач акушер-гинеколог

Россия, 119991, г. Москва, ул. Трубецкая, 8, стр. 2

Россия, 107120, г. Москва, ул. Сергия Радонежского, 5/2, стр. 1



В. А. Пронина
Первый Московский государственный медицинский университет им. И.М. Сеченова (Первый МГМУ им. И.М. Сеченова)
Россия
студентка, 6-й курс, Институт клинической медицины

Россия, 119991, г. Москва, ул. Трубецкая, 8, стр. 2


Е. В. Виривская
Сеть семейных медицинских центров (ССМЦ)
Россия
канд. мед. наук, врач акушер-гинеколог

Россия, 107120, г. Москва, ул. Сергия Радонежского, 5/2, стр. 1


Список литературы

1. Thomas T.G. A Practical treatise upon the diseases of women. The American Journal of the Medical Sciences. 1879; 73 (155): 233–234. DOI: 10.1097/00000441-187907000-00038.

2. Skene A.J. Diseases of the external organs of generation. Treatise on the diseases of women. New York: D Appleton & Co. 1888; 77–99.

3. Moyal-Barracco M., Lynch P.J. 2003 ISSVD terminology and classification of vulvodynia: a historical perspective. J. Reprod. Med. 2004; 49 (10): 772–777.

4. Vieira-Baptista P., Lima-Silva J., Cavaco-Gomes J., Beires J. Prevalence of vulvodynia and risk factors for the condition in Portugal. International Journal of Gynecology & Obstetrics. 2014; 127 (3): 283–287. DOI: 10.1016/j.ijgo.2014.05.020.

5. Basson R. The recurrent pain and sexual sequelae of provoked vestibulodynia: A perpetuating cycle. Sex. Med. 2012; 9 (8): 2077–2092. DOI: 10.1111/j.1743-6109.2012.02803.x.

6. Hooker A.B., Moorst B.R., Haarst E.P., Ootegehem N.A., Dijken D.K., Heres M.H. Chronic pelvic pain: evaluation of the epidemiology, baseline demographics, and clinical variables via a prospective and multidisciplinary approach. Clin. Exp. Obstet. Gynecol. 2013; 40 (4): 492–498.

7. Федорова А.И. Проблемы женского полового влечения и гормональная контрацепция. Акушерство и гинекология. 2014; 3: 91–95.

8. Harlow B.L., Stewart E.G. A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J. Am. Mel. Womens Assoc. 2003; 58 (2): 82–88.

9. Reed B.D., Harlow S.D., Sen A., Legocki L.J., Edwards R.M., Arato N., Haefner H.K. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am. J. Obstet. Gynecol. 2012; 206 (2): 170.e1–170.9. DOI: 10.1016/j.ajog.2011.08.012.

10. Metts J.F. Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. Am. Fam Physician. 1999; 59 (6): 1547–1562.

11. Nguyen R.H., Swanson D., Harlow B.L. Urogenital infections in relation to the occurrence of vulvodynia. J. Reprod. Med. 2009; 54 (6): 385–392.

12. Harlow B.L., Kunitz C.G., Nguyen R.H.N., Rydell S.A., Turner R.M., MacLehose R.F. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am. J. Obstet. Gynecol. 2014; 210 (1): 40.e1–40.8. DOI: 10.1016/j.ajog.2013.09.033.

13. Reed B.D., Legocki L.J., Plegue M.A., Sen A., Haefner H.K., Harlow S.D. Factors associated with vulvodynia incidence. Obstetrics & Gynecology. 2014; 123 (2, Pt 1): 225–231. DOI: 10.1097/AOG.0000000000000066.

14. Eastwood J., Johnson B.D., Rutledge T. et al. Anginal symptoms, coronary artery disease, and adverse outcomes in black and white women: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. J. Womens Health. 2013; 22 (9): 724–732. DOI: 10.1089/jwh.2012.4031.

15. Groysman V. Vulvodynia: new concepts and review of the literature. Dermatol. Clin. 2010; 28 (4): 681–696. DOI: 10.1016/j.det.2010.07.002.

16. Gardella B., Porru D., Nappi R.E., Daccò M.D., Chiesa A., Spinillo A. Interstitial cystitis is associated with vulvodynia and sexual dysfunction – a Case Control Study. J. Sex. Med. 2011; 8: 1726–1734. DOI: 10.1111/j.1743-6109.2011.02251.x.

17. McCormack W.M. Two urogenital sinus syndromes. Interstitial cystitis and focal vulvitis. J. Reprod. Med. 1990; 35 (9): 873–876.

18. Fitzpatrick C.C., DeLancey J.O., Elkins T.E. et al. Vulvar vestibulitis and interstitial cystitis; a disorder of urogenital sinus-derived epithelium. Obstet. Gynecol. 1993; 81 (5): 860–862.

19. Goetsch M.F. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am. J. Obstet. Gynecol. 1991; 164 (6 Pt 1): 1609–1614. DOI: 10.1016/0002-9378(91)91444-2.

20. Foster D.C., Piekarz K.H., Murant T.I., LaPoint R., Haidaris C.G., Phipps R.P. Enhanced synthesis of pro inflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am. J. Obstet. Gynecol. 2007; 196 (4): 346.e1–8. DOI: 10.1016/j.ajog.2006.12.038.

21. Bohm-Starke N., Hilliges M., Falconer C., Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol. Obstet. Invest. 1998; 46 (4): 256–260. DOI: 10.1159/000010045.

22. Tympanidis P., Terenghi G., Dowd P. Increased innervation of the vulvar vestibule in patients with vulvodynia. Br. J. Dermatol. 2003; 148 (5): 1021–1027. DOI: 10.1046/j.1365-2133.2003.05308.x.

23. Westrom L.V., Wille´n R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet. Gynecol. 1998; 91 (4): 572–576.

24. Krantz K.E. Innervation of the human vulva and vagina; a microscopic study. Obstet. Gynecol. 1958; 12 (4): 382–396.

25. Heddini U., Bohm-Starke N., Nilsson K.W., Johannesson U. Provoked vestibulodynia – medical factors and comorbidity associated with treatment outcome. J. Sex. Med. 2012; 9 (5): 1400–1406. DOI: 10.1111/j.1743-6109.2012.02665.x.

26. Foster D.C., Sazenski T.M., Stodgell C.J. Impact of genital variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J. Reprod. Med. 2004; 49 (7): 503–509.

27. Hampson J.P., Reed B.D., Clauw D.J., Bhavsar R., Gracely R.H., aefner H.K., Harris R.E. Augmented central pain processing in vulvodynia. Pain. 2013; 14 (6): 579–589. DOI: 10.1016/j.jpain.2013.01.767.

28. Pukall C.F., Binik Y.M., Khalifé S., Amsel R., Abbott F.V. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain. 2002; 96 (1–2): 163–175. DOI: 10.1016/s0304-3959(01)00442-0.

29. Tympanidis P., Casula M.A., Yiangou Y., Terenghi G., Dowd P., Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur. J. Pain. 2004; 8 (2): 129–133. DOI: 10.1016/S1090-3801(03)00085-5.

30. Babula O., Danielsson I., Sjoberg I., Ledger W.G. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 2004; 191 (3): 762–766. DOI: 10.1016/j.ajog.2004.03.073.

31. Lev-Sagie A., Prus D., Linhares I.M., Nyberg F., Nilsson K.W., Johannesson U. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol. 2009; 200 (3): 303.e1–6. DOI: 10.1016/j.ajog.2008.10.039.

32. Gerber S., Bongiovanni A.M., Ledger W.J., Witkin S.S. Interleukin-1b gene polymorphism in women with vulvar vestibulitis syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003; 107 (1): 74–77. DOI: 10.1016/s0301-2115(02)00276-2.

33. Goldstein A.T., Belkin Z.R., Krapf J.M., Song W., Khera M., Jutrzonka S.L., Kim N.N., Burrows L.J., Goldstein I. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J. Sex. Med. 2014; 11 (11): 2764–2771. DOI: 10.1111/jsm.12668.

34. Johannesson U., de Boussard C.N., Brodda Jansen G., Bohm-Starke N. Evidence of diffuse noxious inhibitory controls (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia. Pain. 2007; 13 (1–2): 31–39. DOI: 10.1016/j.pain.2006.10.022.

35. Meczekalski B., Podfigurna-Stopa A., Warenik-Szymankiewicz A., Genazzani A.R. Functional hypothalamic amenorrhea: Current view on neuroendocrine aberrations. Gynecol. Endocrinol. 2008; 24 (1): 4–11. DOI: 10.1080/09513590701807381.

36. Siddle N., Sarrel P., Whitehead M. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil. Steril. 1987; 47 (1): 94–100. DOI: 10.1016/s0015-0282(16)49942-5.

37. Burrows L.J., Basha M., Goldstein A.T. The effects of hormonal contraceptives on female sexuality: a review. J. Sex. Med. 2012; 9 (9): 2213–2223. DOI: 10.1111/j.1743-6109.2012.02848.x.

38. Bohm-Starke N., Johannesson U., Hilliges M., Rylander E., Torebjörk E. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? J. Reprod. Med. 2004; 49 (11): 888–892.

39. Battaglia C., Morotti E., Persico N., Battaglia B., Busacchi P., Casadio P., Paradisi R., Venturoli S. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. J. Sex. Med. 2014; 11 (2): 471–480. DOI: 10.1111/jsm.12392.

40. Bazin S., Bouchard C., Brisson J., Morin C., Meisels A., Fortier M. Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet. Gynecol. 1994; 83 (11): 47–50.

41. Bouchard C., Brisson J., Fortier M., Morin C., Blanchette C. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am. J. Epidemiol. 2002; 156 (93): 254–261. DOI: 10.1093/aje/kwf037.

42. Harlow B.L., Vitonis A.F., Stewart E.G. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J. Reprod. Med. 2008; 53 (2): 102–110.

43. Greenstein A., Ben-Aroya Z., Fass O., Militscher I., Roslik Y., Chen J., Abramov L. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J. Sex. Med. 2007; 4 (6): 1679–1683. DOI: 10.1111/j.1743-6109.2007.00621.x.

44. Burrows L.J., Goldstein A.T. The treatment of vestibulodynia with topical estradiol and testosterone. Sex. Med. 2013; 1 (1): 30–33. DOI: 10.1002/sm2.4.

45. Edwards L. Vulvodynia. Clinical Obstetrics and Gynecology. 2015; 58 (1): 143–152. DOI: 10.1097/GRF.0000000000000093.

46. Reed B.D., Harlow S.D., Legocki L.J., Helmuth M.E., Haefner H.K., Gillespie B.W., Sen A. Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG. 2013; 120 (13): 1678–1684. DOI: 10.1111/1471-0528.12407.

47. Федорова А.И. Комплексный подход к лечению вульводинии. Акушерство и гинекология. 2014; 8: 112–116.

48. Haefner H.K., Collins M.E., Davis G.D., Edwards L., Foster D.C., Hartmann E.H., Kaufman R.H., Lynch P.J., Margesson L.J., Moyal-Barracco M., Piper C.K., Reed B.D., Stewart E.G., Wilkinson E.J. The vulvodynia guideline. J. Low Genit. Tract Dis. 2005; 9 (1): 40–51. DOI: 10.1097/00128360-200501000-00009.

49. LeClair C., Goetsch M., Korcheva V., Anderson R., Peters D., Morgan T.K. Differences in primary compared with secondary vestibulodynia by immunohistochemistry. Obstet. Gynecol. 2011; 117 (6): 1307–16313. DOI: 10.1097/AOG.0b013e31821c33dc.

50. Shah M., Hoffstetter S. Vulvodynia. Obstetrics and Gynecology Clinics of North America. 2014; 41 (3): 453–464. DOI: 10.1016/j.ogc.2014.05.005.

51. Sadownik L.A. Clinical profile of vulvodynia patients. A prospective study of 300 patients. J. Reprod. Med. 2000; 45 (8): 679–684.

52. Brown C.S., Foster D.C., Bachour C.C., Rawlinson L.A., Wan J.Y., Bachmann G.A. Presenting symptoms among black and white women with provoked vulvodynia. J.Womens Health (Larchmt). 2015; 24 (10): 831–836. DOI: 10.1089/jwh.2014.5164.

53. Gansky S.A., Plesh O. Widespread pain and fibromyalgia in a biracial cohort of young women. J. Rheumatol. 2007; 34 (4): 810–817.

54. Reed B.D, Harlow S.D, Sen A., Edwards R.M., Chen D., Haefner H.K. Relationship between vulvodynia and chronic comorbid pain conditions. Obstet. Gynecol. 2012; 120 (1): 145–151. DOI: 10.1097/AOG.0b013e31825957cf.

55. Tribo M.J., Andio O., Ros S., Sen A. Clinical characteristics and psychopathological profile of patients with vulvodynia: an observational and descriptive study. Dermatology. 2008; 216 (1): 24–30. DOI: 10.1159/000109354.

56. Khandker M., Brady S.S., Vitonis A.F., Maclehose R.F., Stewart E.G., Harlow B.L. The influence of depression and anxiety on risk of adult onset vulvodynia. J. Womens Health (Larchmt). 2011; 20 (10): 1445–1451. DOI: 10.1089/jwh.2010.2661.

57. Turk D.C., Dworkin R.H., Allen R.R., Bellamy N., Brandenburg N., Carr D.B., Cleeland C., Dionne R., Farrar J.T., Galer B.S., Hewitt D.J., Jadad A.R., Katz N.P., Kramer L.D., Manning D.C., McCormick C.G., McDermott M.P., McGrath P., Quessy S., Rappaport B.A., Robinson J.P., Royal M.A., Simon L., Stauffer J.W., Stein W., Tollett J., Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003; 106 (3): 337–345. DOI: 10.1016/j.pain.2003.08.001.

58. Abramov L., Wolman I., David M.P. Vaginismus: an important factor in the evaluation and management of vulvar vestibulitis syndrome. Gynecol. Obstet. Invest. 1994; 38 (3): 194–197. DOI: 10.1159/000292478.

59. Haefner H.K. Vulvovaginal disease update vulvodynia. Durham. 2013.

60. Gentilcore-Saulnier E., McLean L., Goldfinger C., Pukall C.F., Chamberlain S. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J. Sex. Med. 2010; 7 (2): 1003–1022. DOI: 10.1111/j.1743-6109.2009.01642. x.

61. Kandyba K., Binik Y.M. Hypnotherapy as a treatment for vulvar vestibulitis syndrome: a case report. J. Sex. Marital. Ther. 2003; 29 (3): 237–242. DOI: 10.1080/00926230390155122.

62. Schlaeger J.M., Xu N., Mejta C.L., Park C.G., Wilkie D.J. Acupuncture for the treatment of vulvodynia: a Randomized Wait-List Controlled Pilot Study. J. Sex. Med. 2015; 12 (4): 1019–1027. DOI: 10.1111/jsm.12830.

63. Coady D., Futterman S., Harris D., Coleman S.H. Vulvodynia and concomitant femoro-acetabular impingement. Journal of Lower Genital Tract Disease. 2015; 19 (3): 253–256. DOI: 10.1097/LGT.0000000000000108.

64. Фриго Н.В., Жукова О.В., Круглова Л.С. Адъювантная терапия пациенток с дистрофическими процессами вульвы и вульводинией. Клиническая дерматология и венерология. 2015; 14 (6): 28–34. DOI: 10.17116/klinderma201514628-34.

65. Donders G.G., Bellen G. Cream with cutaneous fibroblast lysate for the treatment of provoked vestibulodynia: a Double-Blind Randomized Placebo-Controlled Crossover Study. J. Low Genital. Tract Dis. 2012; 16 (4): 12–16. DOI: 10.1097/LGT.0b013e31825a2274.

66. Ventolini G. Measuring treatment outcomes in women with vulvodynia. J. Clin. Med. Res. 2011; 3 (2): 59–64. DOI: 10.4021/jocmr526w.

67. Brown C.S., Wan J., Bachmann G., Rosen R. Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia. J. Womens Health (Larchmt). 2009; 18 (2): 163–169. DOI: 10.1089/jwh.2007.0676 .

68. Foster D.C., Kotok M.B., Huang L.S., Watts A., Oakes D., Howard F.M., Poleshuck E.L., Stodgell C.J., Dworkin R.H.. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet. Gynecol. 2010; 116 (3): 583–593. DOI: 10.1097/AOG.0b013e3181e9e0ab.

69. Meltzer-Brody S.E., Zolnoun D., Steege J.F., Rinaldi K.L., Leserman J. Open-label trial of lamotrigine focusing on efficacy in vulvodynia. J. Reprod. Med. 2009; 54 (3): 171–178.


Для цитирования:


Бахтияров К.Р., Буданов П.В., Пронина В.А., Виривская Е.В. Вульводиния – мультидисциплинарная проблема. Бюллетень сибирской медицины. 2020;19(1):114-124. https://doi.org/10.20538/1682-0363-2020-1-114-124

For citation:


Bakhtiyarov K.R., Budanov P.V., Pronina V.A., Virivskaia E.V. Vulvodynia – a multidisciplinary problem. Bulletin of Siberian Medicine. 2020;19(1):114-124. (In Russ.) https://doi.org/10.20538/1682-0363-2020-1-114-124

Просмотров: 115


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-0363 (Print)
ISSN 1819-3684 (Online)